- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC's ACO Coalition Is Proud to Announce Suzanne F. Delbanco, PhD, MPH, of Catalyst for Payment Reform as Keynote Speaker
Suzanne F. Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform, will be the keynote speaker at the spring meeting of the ACO and Emerging Healthcare Delivery Coalition, to be held April 30 and May 1, 2015, in San Diego, California. The ACO Coalition, an initiative of The American Journal of Managed Care, brings together stakeholders from across the healthcare spectrum interested in sharing best practices relative to the changing delivery and payment models.
FOR IMMEDIATE RELEASEMarch 3, 2015AJMC’s ACO Coalition Is Proud to Announce Suzanne F. Delbanco, PhD, MPH, of Catalyst for Payment Reform as Keynote Speaker
PLAINSBORO, N.J.—The ACO and Emerging Healthcare Delivery Coalition, an initiative of The American Journal of Managed Care (AJMC), welcomes Suzanne F. Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform, as its keynote speaker for the spring meeting of the Coalition. The meeting will be April 30-May 1, 2015, at the Hotel del Coronado in San Diego, California.
Dr Delbanco leads a non-profit organization that seeks to engage the largest purchasers of healthcare and health plans to reform the way healthcare is paid for in the United States. She also serves on the Coordinating Committee of the Measures Application Partnership for HHS, and the Health Care Incentives Improvement Institute Board.
The founding chief executive officer of The Leapfrog Group, Dr Delbanco also participates in the Healthcare Executives Leadership Network and is the author or co-author of peer-reviewed articles in the New England Journal of Medicine, the American Journal of Medical Quality, and many other publications. Recently, she wrote about formation of accountable care organizations for The American Journal of Accountable Care, AJMC’s new publication on healthcare reform and emerging delivery models.
Dr Delbanco holds a PhD from the Goldman School of Public Policy and an MPH from the School of Public Health at the University of California, Berkeley.
Since its inception more than a year ago, the ACO Coalition has held live meetings in Baltimore, Maryland, and Miami, Florida, and hosted a series of WebEx sessions featuring experts from academia, clinical care, and hospital administration. The Coalition has grown to 165 members. Live meetings include case studies, interactive workshops, and networking opportunities. Sessions have covered diverse topics from payment models, to technology, to deploying care coordinators to improve diabetes care. Those interested in learning more about San Diego meeting and the ACO Coalition are encouraged to contact Nicole Beagin, associate editorial director of The American Journal of Managed Care, at nbeagin@ajmc.com or (609) 716-7777 x 131.
About the ACO Coalition
As ACOs and other emerging delivery and payment models evolve and move away from traditional fee-for-service system models toward cost-effective and value-based care, the need to understand how these models will evolve is critical to building long-term strategic solutions. The mission of the ACO Coalition is to bring together a diverse group of key stakeholders, including ACO providers and leaders, payers, IDNs, retail and specialty pharmacy, academia, national quality organizations, patient advocacy and pharmaceutical manufacturers to work collaboratively to build value and improve the quality and overall outcomes of patient care. Coalition members share ideas and best practices through live meetings, Web-based interactive sessions and conference calls. Distinguishing features are the Coalition’s access to leading experts and its small workshops that allow creative problem-solving. To learn more, click here.
About the Journals
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Nicole Beagin (609) 716-7777 x 131
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
